Psychemedics Stock Working Capital
| PMD Stock | USD 2.55 0.09 3.41% |
Psychemedics fundamentals help investors to digest information that contributes to Psychemedics' financial success or failures. It also enables traders to predict the movement of Psychemedics Stock. The fundamental analysis module provides a way to measure Psychemedics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Psychemedics stock.
| Last Reported | Projected for Next Year | ||
| Net Working Capital | 2.1 M | 2 M | |
| Change In Working Capital | -1.7 M | -1.6 M | |
| Working Capital | 0.00 | 0.00 |
Psychemedics | Working Capital |
Psychemedics Company Working Capital Analysis
Psychemedics' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Psychemedics Working Capital | 2.1 M |
Most of Psychemedics' fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Psychemedics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Psychemedics Working Capital Driver Correlations
Understanding the fundamental principles of building solid financial models for Psychemedics is extremely important. It helps to project a fair market value of Psychemedics Stock properly, considering its historical fundamentals such as Working Capital. Since Psychemedics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Psychemedics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Psychemedics' interrelated accounts and indicators.
Click cells to compare fundamentals
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Psychemedics Capital Surpluse
Capital Surpluse |
|
Based on the company's disclosures, Psychemedics has a Working Capital of 2.1 M. This is 99.51% lower than that of the Health Care Providers & Services sector and 99.55% lower than that of the Health Care industry. The working capital for all United States stocks is 99.86% higher than that of the company.
Psychemedics Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Psychemedics' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Psychemedics could also be used in its relative valuation, which is a method of valuing Psychemedics by comparing valuation metrics of similar companies.Psychemedics is currently under evaluation in working capital category among related companies.
Psychemedics Fundamentals
| Return On Equity | -0.48 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | (0.19) % | ||||
| Operating Margin | (0.17) % | ||||
| Current Valuation | 15.64 M | ||||
| Shares Outstanding | 5.81 M | ||||
| Shares Owned By Insiders | 22.70 % | ||||
| Shares Owned By Institutions | 22.30 % | ||||
| Number Of Shares Shorted | 16.88 K | ||||
| Price To Earning | 92.08 X | ||||
| Price To Book | 2.40 X | ||||
| Price To Sales | 0.72 X | ||||
| Revenue | 22.1 M | ||||
| Gross Profit | 9.29 M | ||||
| EBITDA | (251 K) | ||||
| Net Income | (4.15 M) | ||||
| Cash And Equivalents | 1.79 M | ||||
| Cash Per Share | 0.32 X | ||||
| Total Debt | 2.3 M | ||||
| Debt To Equity | 0.36 % | ||||
| Current Ratio | 2.06 X | ||||
| Book Value Per Share | 1.15 X | ||||
| Cash Flow From Operations | (1.48 M) | ||||
| Short Ratio | 1.79 X | ||||
| Earnings Per Share | (0.72) X | ||||
| Target Price | 32.0 | ||||
| Number Of Employees | 116 | ||||
| Beta | 0.7 | ||||
| Market Capitalization | 15.31 M | ||||
| Total Asset | 13.27 M | ||||
| Retained Earnings | (16.77 M) | ||||
| Working Capital | 2.1 M | ||||
| Current Asset | 8.46 M | ||||
| Current Liabilities | 3.56 M | ||||
| Annual Yield | 0.11 % | ||||
| Five Year Return | 5.18 % | ||||
| Net Asset | 13.27 M | ||||
| Last Dividend Paid | 0.07 |
About Psychemedics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Psychemedics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Psychemedics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Psychemedics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Psychemedics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Psychemedics Piotroski F Score and Psychemedics Altman Z Score analysis. For information on how to trade Psychemedics Stock refer to our How to Trade Psychemedics Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Psychemedics Stock analysis
When running Psychemedics' price analysis, check to measure Psychemedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psychemedics is operating at the current time. Most of Psychemedics' value examination focuses on studying past and present price action to predict the probability of Psychemedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psychemedics' price. Additionally, you may evaluate how the addition of Psychemedics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Psychemedics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psychemedics. If investors know Psychemedics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psychemedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Dividend Share 0.07 | Earnings Share (0.72) | Revenue Per Share 3.85 | Quarterly Revenue Growth (0.12) |
The market value of Psychemedics is measured differently than its book value, which is the value of Psychemedics that is recorded on the company's balance sheet. Investors also form their own opinion of Psychemedics' value that differs from its market value or its book value, called intrinsic value, which is Psychemedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psychemedics' market value can be influenced by many factors that don't directly affect Psychemedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psychemedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Psychemedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psychemedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.